Literature DB >> 1453875

Amylin.

B J Edwards1, J E Morley.   

Abstract

Amylin is a 37 amino-acid peptide which is secreted from the pancreatic islets of Langerhans. It has major sequence homology with calcitonin gene related peptide. Amylin can precipitate out in these cells to form amyloid. Amylin is secreted by similar stimuli to those that secrete insulin. Amylin has a number of effects that may counteract the effect of secreted insulin, i.e., decreased second phase insulin secretion, increased hepatic glucose output, and inhibition of insulin effects on skeletal muscle. It must, however, be recognized that in many cases the doses necessary to produce these effects appear to be supraphysiological. The putative role of amylin in the hyperglycemia of aging and Type II diabetes mellitus therefore remains controversial. Amylin has a number of other effects including inhibition of osteoclastic activity, vasodilatation, anorectic effects and enhanced memory retention. This review postulates a role for amylin in the pathogenesis of a number of age-related changes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1453875     DOI: 10.1016/0024-3205(92)90106-y

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

2.  Non-competitive antagonism of amylin on CGRP(1)-receptors in rat coronary small arteries.

Authors:  M Sheykhzade; N C Nyborg
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 3.  Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.

Authors:  C Oosterwijk; J W Höppener; K L van Hulst; C J Lips
Journal:  Int J Pancreatol       Date:  1995-08

Review 4.  Anorexia in older persons: epidemiology and optimal treatment.

Authors:  J E Morley
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.